Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate

Phase 2

Completed

Conditions: Osteoporosis, Postmenopausal

Interventions: Dietary Supplement: Coral Complex 3
Drug: Ibandronate
Dietary Supplement: Vitamin D3

First Posted Date: 2020-03-25

Last Posted Date: 2024-05-09

Lead Sponsor: Columbia University

Target Recruit Count: 60

Registration Number: NCT04321837

Locations: 🇦🇲
Osteoporosis Center of Armenia, Yerevan, Armenia

Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)

Phase 2

Recruiting

Conditions: Corona Virus Infection
COVID-19

Interventions: Drug: Hydroxychloroquine
Drug: Placebo oral tablet

First Posted Date: 2020-03-24

Last Posted Date: 2020-04-27

Lead Sponsor: Columbia University

Target Recruit Count: 1600

Registration Number: NCT04318444

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Well-being Promotion and Sleep Hygiene Education to Improve Sleep Quality

Not Applicable

Completed

Conditions: Poor Quality Sleep

Interventions: Behavioral: Well-Being Intervention
Behavioral: Sleep Hygiene

First Posted Date: 2020-03-20

Last Posted Date: 2023-04-27

Lead Sponsor: Columbia University

Target Recruit Count: 76

Registration Number: NCT04316663

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Early Phase 1

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Degarelix
Drug: BMS-986218 and Degarelix

First Posted Date: 2020-03-10

Last Posted Date: 2024-07-09

Lead Sponsor: Columbia University

Target Recruit Count: 26

Registration Number: NCT04301414

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

The Effect of Maternal Scent on Sleep Wake States

Not Applicable

Completed

Conditions: Development, Infant

Interventions: Other: Maternal Scent

First Posted Date: 2020-03-10

Last Posted Date: 2022-08-26

Lead Sponsor: Columbia University

Target Recruit Count: 78

Registration Number: NCT04301453

Locations: 🇺🇸
New York Presbyterian, Columbia University Medical Center, New York, New York, United States

Targeted Fortification of Donor Breast Milk in Preterm Infants

Not Applicable

Recruiting

Conditions: Failure to Thrive in Newborn
Growth Retardation
Prematurity; Extreme
Growth Failure
Infant Nutrition Disorders

Interventions: Dietary Supplement: Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid
Dietary Supplement: Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid (Targeted Fortification)
Dietary Supplement: Similac Liquid Protein Fortifier
Dietary Supplement: Similac Liquid Protein Fortifier (Targeted Fortification)
Dietary Supplement: Nestle Microlipid
Dietary Supplement: Nestle Microlipid (Targeted Fortification)
Dietary Supplement: Medica Nutrition SolCarb (Targeted Fortification)
Dietary Supplement: Medica Nutrition SolCarb
Other: Analysis with Miris (AB) Human Milk Analyzer